Affiliation:
1. Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA
Abstract
Abstract
Learning Objectives
After completing this course, the reader should be able to: Explain the difference between exploratory (hypothesis-generating) analyses and confirmatory (hypothesis-testing) analyses.Describe why a statistical test result (p-value) only expresses the likelihood that the result could have occurred by chance and does not prove the truth of the study.Define what a hazard ratio expresses.
CME This article is available for continuing medical education credit at CME.TheOncologist.com
Modern clinical trials provide the evidence for most therapeutic advances, and that evidence, expressed in a statistical format, is used to draw inferences about a population from the study's results. Clinician judgment translates these inferences for best individual patient care, but many clinicians struggle with the statistical interpretation of trial results. This review provides a clinical and non-Bayesian perspective on some key elements in the statistical design, analysis, and interpretation of randomized, comparative, phase III clinical trials intended to demonstrate a better outcome (superiority) than with a control treatment.
Publisher
Oxford University Press (OUP)
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献